Share Capital - Summary Of Option Activity (Detail) - $ / shares |
12 Months Ended | ||||||
|---|---|---|---|---|---|---|---|
Dec. 31, 2025 |
Dec. 31, 2024 |
Dec. 31, 2023 |
|||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
| Granted units | 0 | 0 | |||||
| Weighted average contractual life | 4 years 6 months 10 days | [1] | 5 years 6 months 10 days | [1] | 6 years 9 months 10 days | ||
| Stock Option [Member] | |||||||
| Share-based Compensation Arrangement by Share-based Payment Award [Line Items] | |||||||
| Beginning balance outstanding | 7,877,000 | [1] | 7,877,000 | ||||
| Ending balance outstanding | 7,877,000 | [1] | 7,877,000 | [1] | 7,877,000 | ||
| Weighted average exercise price beginning balance | $ 0.05 | [1] | $ 0.05 | ||||
| Weighted average exercise price ending balance | $ 0.05 | [1] | $ 0.05 | [1] | $ 0.05 | ||
| |||||||
| X | ||||||||||
- Definition Line items represent financial concepts included in a table. These concepts are used to disclose reportable information associated with domain members defined in one or many axes to the table. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Gross number of share options (or share units) granted during the period. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Number of options outstanding, including both vested and non-vested options. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average price at which grantees can acquire the shares reserved for issuance under the stock option plan. Reference 1: http://www.xbrl.org/2003/role/disclosureRef
|
| X | ||||||||||
- Definition Weighted average remaining contractual term for option awards outstanding, in 'PnYnMnDTnHnMnS' format, for example, 'P1Y5M13D' represents the reported fact of one year, five months, and thirteen days. Reference 1: http://fasb.org/us-gaap/role/ref/legacyRef
|
| X | ||||||||||
- Details
|